Saint Luke's Newsroom

Jun. 17, 2021

Courier Tribune: Saint Luke’s robot brings new surgical options to Northland patients

The Courier Tribune talked to Dr. Benjamin Kulow about the advantages of robotic surgery and how the state-of-the-art technology is advancing patient care in the Northland.
Jun. 15, 2021

KSHB: US seeing national birth rate decline

KSHB talked to Dr. Lori Kramer about how many women are waiting to have children later in life.
Jun. 11, 2021

HCP Live: The Significance of DAPA-HF for Cardiovascular Care and Beyond

HCP Live talked to Dr. Mikhail Kosiborod about the clinical impact of the DAPA-HF trial. 
Jun. 10, 2021

KSHB: Patient helps raise awareness for NASH

Steve Lack, a patient at Saint Luke’s Liver Disease Management, talks to KSHB about his journey with NASH, why he participated in a clinical trial for NASH and still comes to Saint Luke's even though he moved nearly three hours away. 
Jun. 10, 2021

KCTV: Saint Luke's Doctor Raises Awareness for NASH

Dr. Laura Alba, Medical Director of Hepatology, Saint Luke’s Liver Disease Management, talks to KCTV about what NASH is, how NASH affects patients, and why research for NASH is so important.
Jun. 10, 2021

KSHB: 'Stop the bleed' increases shooting victim survival rate

The trauma director at Saint Luke's Hospital of Kansas City, spoke with KSHB about the trauma team that mobilizes once an ambulance arrives, what has changed over the years in treating trauma victims, and why 'Stop the Bleed' is so important.
Jun. 9, 2021

KSHB: Adolescent substance abuse on the rise amid pandemic

KSHB talked to Molly Pellettiere about how substance abuse in teens can impact brain development.
Jun. 9, 2021

KSHB: Expert shares how to help children process grief, violence

KSHB talked to Amanda Davis about the emotional impact of shootings and homicides on the community and how to help children process it all.
Medscape logo
Jun. 8, 2021

Medscape: Mavacamten Boosts Quality of Life in Hypertrophic Cardiomyopathy

Medscape details the promising findings of the EXPLORER-HCM Phase 3 Trial presented by Dr. John Spertus at the 2021 ACC Scientific Session.